Search

You searched for "wellbeing"

1624 results found

New OCULUS distributor for UK and Ireland

15 February 2024 | Contracts & Distributors
OCULUS Optikgeräte GmbH and Mainline Instruments Announce UK and Ireland Distribution Agreement

The Worshipful Company of Spectacle Makers awards two Master’s Medals for early career research

21 October 2025 | WCSM, early career, awards, genetics, AI
The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of two Master’s Medals for 2025. Fabian Yii from Edinburgh was awarded the Master’s Medal for his paper, 'Fundus Refraction Offset as a Personalized Biomarker for 12-Year Risk...

OSA chair passes to a delighted James Conway

11 December 2025 | optometry, industry news, leadership
Longstanding OSA Director James Conway is delighted to have been appointed as the new OSA Chair, following the retirement of Roy Stoner after a three-year tenure. The OSA’s AGM and Christmas lunch at the Bloomsbury Hotel, London, saw Roy pass...

Eye research: where next?

1 December 2017
Eye research in the UK is underfunded relative to other areas of medical research and general awareness of sight loss and its prevention remains poor, messages that were reinforced in presentations and discussions during a recent research summit meeting in...

See sweet to C-suite: Imran Rahman

4 February 2025 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma
See also - See sweet to C-suite: Peter Holland In this three-part conversation series, Co-editor David Lockington speaks with highly influential individuals about their journey to the top, with advice for the next generation of leaders. Part Two: David speaks...

A trip up north: Eye News Symposium 2020

24 February 2020
New accents, friendly smiles and haggis served with my traditional morning breakfast, I knew at this point that I was a long way from the south of England, where this story begins.

Effective treatment for rare sight-threatening infection

1 November 2023 | Moorfields, UCL, SIFI S.p.A., Acanthamoeba, keratitis, corneal infection
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.

Genetic therapy gives infants life-changing improvements in sight

24 February 2025 | genetics, gene therapy, Moorfields, paediatrics, research, new, AIPL1, Leber Congenital Amaurosis
Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through Moorfields Eye Hospital and UCL Institute of Ophthalmology, with the support of MeiraGTx. The children were born with a severe impairment to...

An environmentally friendly eye service

1 August 2025 | | climate change, sustainability news, net zero, greenhouse gases, environment
A single cataract procedure in the UK has been estimated to have a carbon footprint equivalent to driving a typical non-electric car for 310 miles. Surprisingly, very few centres around the world have worked out the environmental cost of cataract...

Has ‘reduce, reuse and recycle’ gone too far?

7 October 2025 | | Sustainability News, environment, climate change, recycling, waste
The past few decades of surgery since the ‘mad cow disease’ have been dominated by a push to switch to disposable instruments. The reason is to prevent cross-contamination and reduce the risk of surgical site infections – especially so with...

Diagnosis and management of IV cranial nerve palsy

1 October 2017 | EYE - Neuro-ophthalmology
Aetiology: Trochlear nerve palsy can be divided into acute or congenital. Congenital trochlear nerve palsy is usually noted in childhood with development of abnormal head posture. Various pathologies can lead to acute IV nerve palsy, most commonly trauma. Other causes...

Managing cataract surgery in a patient with diabetic maculopathy

1 August 2016 | | EYE - Cataract, EYE - Refractive
A 56-year-old type 2 diabetic with previously treated bilateral diabetic maculopathy develops a cataract requiring surgery in the right eye. He has had grid laser previously, followed intermittently by intravitreal triamcinalone, Avastin and more recently Lucentis in both eyes. His...